Wednesday, April 22, 2009

Colorado BioScience Association Names Rick Jory Board Chair

Denver, CO, April 22, 2009 -- Rick Jory, CEO of Sandhill Scientific, Inc. (http://www.sandhillsci.com/), Highlands Ranch, was named chairperson of the board of directors for the Colorado BioScience Association (CBSA) at its 2009 annual all-member meeting held at the Colorado National Golf Club facilities in Erie, CO, yesterday. The announcement is made by John Collar, CBSA President & CEO, who says Jory assumes chairperson responsibilities from Jack Wheeler, entrepreneur and founder of MicroPhage, Inc.

Prior to introducing Jory to the CBSA membership, Wheeler announced the following 2009 association sponsors: Platinum - Cooley Godward Kronish, Colorado State University, and the University of Colorado. Gold - Colorado Science + Technology Park at Fitzsimons, Merck & Co., Inc. and Snell & Wilmer Silver - Amgen, CaridianBCT, Denver Museum of Nature & Science, Ernst & Young, Fitzsimons Redevelopment Authority, and Pfizer. Bronze - Baxa Corporation, Dorsey & Whitney, Fairfield & Woods, Hogan & Hartson, Holland & Hart, Johnson & Johnson, OSI Pharmaceuticals, PhRMA, Poisinelli Shughart and We Work for Health.


Friday, April 10, 2009

Rocky Mountain Life Science Investor Conference: Coming September 17th in Denver


See the future of healthcare at the Rocky Mountain region’s first and only life science investor conference, September 17th at the Ritz Carlton in Denver. The Rocky Mountain Life Science Investor Conference is bringing together leading investors, emerging companies and senior executives to cultivate partnerships within the industry.
  • Thirty of this region’s most innovative private and public life science companies will present to a targeted audience of device, diagnostic and pharma investors. Registration begins April 20, 2009.

  • Presenting companies will find partnering opportunities throughout the day. To maximize time at the conference, biopartnering.com facilitates connection with potential partners weeks in advance and follow-up after the conference. Partnering opens July 20th, 2009.
The Rocky Mountain region is the largest and most advanced area between both coasts, garnering more than $10 billion dollars in financings and acquisitions since the end of 2006.

Friday, April 3, 2009

CBSA's John Collar Interviewed on w3w3's Colorado Rising broadcast




Colorado Rising 03/23/09
2:00 - Phil Weiser, Silicon Flatirons
2:15 - Terry Gold, Gold Systems
2:30 - John Collar, Colorado BioScience Association
2:45 - Charlotte Waisman & Jill Tietjen Her Story A Timeline


Denver Post Jobs Weekly Touts Colorado's Booming Bioscience Sector to Job Hunters










The Denver Post Jobs Weekly featured Colorado's bioscience industry to job hunters on Sunday, March 29. "Bioscience inventing healing, smart-track futures," included information from CBSA's President & CEO John Collar.
As the article says, "It can pay to discover bioscience."

Denver Post: On front line in cancer fight - Colorado, with several drugs in research stages, is seen as a "significant" player.

In a nod to Colorado's booming biotech industry, Pharmaceutical Research and Manufacturers of America issued a report in Denver on Wednesday responding to President Barack Obama's call in February for "a cure for cancer in our time."

"Colorado is clearly becoming one of the significant players in terms of oncology drug development," said Timothy Rodell, chief executive of GlobeImmune, a Louisville company founded by three University of Colorado scientists. "There is lot happening here right now."

Link to the Denver Post article